News
The Lumipulse G Plasma Ratio Test offers a new way to detect signs of Alzheimer's disease by identifying plaque proteins in ...
The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
7h
GlobalData on MSNFDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’sThe US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
The FDA cleared the test for the early detection of amyloid plaques associated with Alzheimer’s in people aged 55 years and ...
Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...
The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...
The U.S. Food and Drug Administration (USFDA) has cleared for marketing the first in vitro diagnostic device that tests blood ...
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward ...
19h
InsideHook on MSNThe FDA Just Approved an Alzheimer's Disease Blood TestIf you or someone you love is concerned about Alzheimer’s disease, the process of detecting its presence can involve a series ...
The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results